DirectorsTalk Interviews LSE London Stock Exchange PLC Company Interviews
Microsaic Systems plc (LON:MSYS) Chief Executive Officer Glenn Tracey caught up with DirectorsTalk for an exclusive interview to discuss the highlights from their final results, what the 12 OEM & ...
Read Article »Home » Q & A (page 2)
Q & A
-
Open Orphan PLC Q&A: Coronavirus challenge study model (LON:ORPH)
-
Open Orphan Q&A with CEO Cathal Friel (LON:ORPH)
-
Cambria Automobiles Q&A with Mike Allen at Zeus Capital (LON:CAMB)
-
TT Electronics Q&A: Strong prospects for 2020 & beyond (LON:TTG)
-
Boku Inc Q&A: Strong start to the year (LON:BOKU)
-
Strix Group Q&A: Processes in place following the Coronavirus outbreak (LON:KETL)
-
AFC Energy Operating with incredible capital efficiency say WH Ireland
-
Jubilee Metals Group Q&A: Significant uptick in earnings & revenue (LON:JLP)
-
Arix Bioscience Analyst Q&A with Dr Dorothea Hill (LON:ARIX)
-
Sativa Group Q&A Alignment with distributors paying off (NEX:SATI)
-
Advanced Oncotherapy Analyst Q&A discussing the LIGHT collaboration (LON:AVO)
-
Analyst Q&A with Hardman & Co: Volta Finance (LON:VTA)
-
1pm plc CEO Q&A: Increased funding facility (LON:OPM)
-
Northbridge Industrial Services Q&A – Return to Growth (LON:NBI)
-
Morses Club Hardman & Co Analyst Q&A (LON:MCL)
-
Non-Standard Finance Analyst Q&A with Hardman & Co (LON:NSF)
-
Norman Broadbent Q&A: Return to profitability (LON:NBB)
-
Q&A: Baden Hill's view on Ilika's half-year report (LON:IKA)
-
Analyst Q&A with Zeus Capital: JTC Group (LON:JTC)
-
Avacta Group Q&A "Strong performance to continue" (LON:AVCT)
-
Cambria Automobiles Analyst Q&A with Zeus Capital (LON:CAMB)
-
DWF Group Analyst Q&A with Zeus Capital (LON:DWF)
-
Analyst Q&A with Hardman & Co CEO Keith Hiscock
-
Touchstone Exploration Q&A: Cascadura well is a real gamechanger (LON:TXP)
-
RM Secured Direct Lending Analyst Q&A with Hardman & Co (LON:RMDL)
-
Real Estate Credit Investments Analyst Q&A (LON:RECI)
-
B-North Q&A with Hardman & Co Analyst Mark Thomas
-
Norman Broadbent Q&A: Partnership with UN Women UK (LON:NBB)
-
Touchstone Exploration Q&A: Transformational oil discovery at Cascadura (LON:TXP)
-
Kromek Group Q&A: More growth to come in the second half (LON:KMK)
-
Versarien Q&A: Significant progress with graphene commercialisation strategy (LON:VRS)
-
ImmuPharma Q&A with The Life Sciences Division (LON:IMM)
-
Pantheon International Analyst Q&A: Significant long-term out-performance (LON:PIN)
-
Hardide Q&A Record revenue & a strong start to new financial year (LON:HDD)
-
Palace Capital Analyst Q&A with Hardman & Co (LON:PCA)
-
Non-Standard Finance Analyst Q&A (LON:NSF)
-
ImmuPharma Q&A: More positive news will continue to strengthen share price (LON:IMM)
-
Gresham House Strategic MD Q&A with Graham Bird (LON:GHS)
-
Premier Miton Investors Q&A with Head of Equities Gervais Williams (LON:PMI)
-
Sativa Group Q&A: New appointments, medicinal cannabis licence & admission to AIM (NEX:SATI)
